Factors Associated with Antimicrobial Use at the End-Of-Life Among Hospitalized Cancer Patients.

ABSTRACT: Background: Antimicrobials are frequently administered at end-of-life (EOL) and their non-beneficial use may subject patients to unnecessary harms. Studies analyzing factors for antimicrobial prescribing in solid tumor cancer patients at the EOL are lacking. Thus, we aimed to identify factors and patterns associated with antimicrobial use in hospitalized adults with cancer at EOL. Methods: We used a retrospective cohort design to review electronic medical records of terminal hospitalized patients ≥18 years with solid tumors admitted to non-intensive care units in a metropolitan comprehensive cancer center during 2019 and assessed antimicrobial use in the last 7 days of life. Results: Among 633 cancer patients, 59% (n = 376) received antimicrobials (AM+) within t

SUBMITTER: Pandey S 

PROVIDER: S-EPMC10442462 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature